Last updated on March 2016

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)


Brief description of study

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Detailed Study Description

A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.

Clinical Study Identifier: TX143109

Contact Investigators or Research Sites near you

Start Over

IMA Research

Kew Gardens, NY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.